Cohort Company News

Genetesis, a Mason startup that’s developing a medical imaging device that could benefit patients with heart problems, raised $7.5 million in a Series A round of funding from a group of investors that includes CincyTech and billionaire Mark Cuban of the TV show “Shark Tank.”

Thanks to transcatheter aortic valve replacement (TAVR), many patients with heart valve disease have a new lease on life. That success is spilling over into mitral and tricuspid heart valve disease, which are both active areas of medical device innovation.

Neural Analytics Inc., a medical device company based in Rancho Park, announced it has cleared a federal hurdle for a robotic system to assist with ultrasound in diagnosing brain trauma.

Access Vascular has raised $1.9 million in a new round of equity financing, according to an SEC filing posted this week. Money in the round came from seven unnamed sources, with the first sale recorded on May 4, according to the filing.

There is one fact that’s universally known by all great entrepreneurs: Launching a business is like jumping on a roller coaster—it can be filled with soaring highs and surprising twists and turns. It’s a way of life that IntuiTap Medical CEO and co-founder Jessica Traver, 27, has become accustomed to since starting her company two years ago, which is focused on providing a game-changing solution to a common, and often painful, procedure: the spinal tap.

Trayt, a Redwood City, California-based data analytics company, has released a mobile application designed to help diagnose, track and treat patients with autism, ADHD and other neurodevelopmental brain disorders.

Johnson & Johnson today announced the acquisition of C-SATS, a Seattle startup that uses technology to facilitate performance reviews for surgeons. Founded in 2014 and spun out of the University of Washington, C-SATS built a cloud-based performance management system that evaluates surgeons and helps improve their skills.

Access Vascular said today that its HydroPICC catheter has won 510(k) clearance from the FDA. The peripherally-inserted central catheter is designed with Access Vascular’s proprietary bulk-hydrophilic material, which the company touted as “the ideal material for long-term implantable vascular access devices.”

PharmaJet has entered a global license agreement with Genexine for the development and commercialization of DNA vaccines for human applications using the PharmaJet needle-free injection systems. 

We're excited to announce the three new startups joining Launchpad Studio, our 6-month mentorship program tailored to help applied-machine learning startups build great products using the most advanced tools and technologies available.

Urology medical device maker Zenflow said today it closed a $31.4 million Series A round of financing to support the development of minimally invasive devices designed to treat obstructive urinary symptoms related to benign prostatic hyperplasia.

Broomfield, CO, January 31, 2018 --(PR.com)-- MedAware Systems, Inc. announced today it is launching the world’s most comprehensive database of evidence on Apheresis, available through its SOHInfo™ division. Data have been meticulously extracted from over 2,300 clinical trials, cohort studies, registries, reviews and other published works, spanning medical journals worldwide.

At the 2017 meeting of AdvaMed, the medical device industry’s advocacy organization, young start-up Day Zero Diagnostics was chosen as this year’s MedTech Innovator Global Competition winner.

Nexeon MedSystems Inc., headquartered in Dallas, Texas, is a medical device company developing a neurostimulator technology platform for the treatment of disorders through the electrical stimulation of neural tissues. The company’s first application of its Nexeon Neurostimulation System will be for the treatment of chronic medical conditions such as Parkinson’s and associated diseases in Europe.